Current Opinion in Oncology

Papers
(The H4-Index of Current Opinion in Oncology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps55
The road to chemotherapy-free treatment in chronic lymphocytic leukaemia38
Can febrile neutropenia re-invent its self?32
Challenges adopting next-generation sequencing in community oncology practice30
First and further-line multidisciplinary treatment of retroperitoneal sarcomas28
Angiogenesis inhibition in lung cancer: emerging novel strategies26
Pathologic diagnosis of lung cancer – recent developments25
Hepatosplenic T-cell lymphoma: treatment challenges21
Treatment of anaplastic gliomas: evidences and controversies21
Editorial introductions20
Editorial: Head and neck squamous cell cancer: ways to optimize the treatment and improve the outcomes19
Editorial introductions17
Opportunities and challenges of neoadjuvant targeted therapy in nonsmall cell lung cancer17
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis17
Breast surgery after neoadjuvant therapy16
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma16
0.057820081710815